Cargando…

Validation and ease of use of a new pen device for self-administration of recombinant human growth hormone: results from a two-center usability study

Close adherence to the recommended treatment regimen is important for the success of recombinant human growth hormone therapy, although nonadherence can be common. Ease of use and safety during use/storage are among several important factors in the design of a growth hormone injection device intende...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rapaport, Robert, Saenger, Paul, Schmidt, Heinrich, Hasegawa, Yukihiro, Colle, Michel, Loche, Sandro, Marcantonio, Sandra, Bonfig, Walter, Zabransky, Markus, Lifshitz, Fima
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2013
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3770891/ https://www.ncbi.nlm.nih.gov/pubmed/24039458 http://dx.doi.org/10.2147/MDER.S50088

Ejemplares similares

Switching to Omnitrope(®) from Other Recombinant Human Growth Hormone Therapies: A Retrospective Study in an Integrated Healthcare System
por: Rashid, Nazia, et al.
Publicado: (2014)

Erratum to: Switching to Omnitrope(®) from Other Recombinant Human Growth Hormone Therapies: A Retrospective Study in an Integrated Healthcare System
por: Rashid, Nazia, et al.
Publicado: (2014)

Psychometric Assessment of the Injection Pen Assessment Questionnaire (IPAQ): measuring ease of use and preference with injection pens for human growth hormone
por: Pleil, Andreas M, et al.
Publicado: (2012)

A new pen device for injection of recombinant human growth hormone: a convenience, functionality and usability evaluation study
por: Sauer, Maritta, et al.
Publicado: (2017)

Satisfaction and usability of the recombinant chorionic gonadotropin prefilled pen: a survey in Italy
por: Dallagiovanna, Chiara, et al.
Publicado: (2022)

Exogenous recombinant human growth hormone effects during suboptimal energy and zinc intake
por: Rising, Russell, et al.
Publicado: (2005)

Single-arm, observational study of the ease of use of a redesigned pen device to deliver recombinant human follicle-stimulating hormone (follitropin alfa) for assisted reproductive technology treatment
por: Illingworth, Peter J, et al.
Publicado: (2014)

Ten years of biosimilar recombinant human growth hormone in Europe
por: Saenger, Paul
Publicado: (2017)

Ease of Use, Preference, and Safety of the Recombinant Human Growth Hormone Disposable Pen Compared with the Reusable Device: A Multicenter, Single-Arm, Open-Label, Switch-Over, Prospective, Phase IV Trial
por: Lee, Ji-Eun, et al.
Publicado: (2019)

Pen needle design influences ease of insertion, pain, and skin trauma in subjects with type 2 diabetes
por: Præstmark, Kezia A, et al.
Publicado: (2016)

Evaluating the usability and safety of the semaglutide single‐dose pen‐injectors through summative (human factors) usability testing
por: Klonoff, David C, et al.
Publicado: (2020)

THU163 Traffic Light Alerting System For Adherence Risk Management To Improve Catch-Up Growth In Patients Receiving Recombinant Human Growth Hormone Therapy
por: Loche, Sandro, et al.
Publicado: (2023)

Obesity in Children
por: Lifshitz, Fima
Publicado: (2008)

Nutrition and Growth
por: Lifshitz, Fima
Publicado: (2009)

Formative usability evaluation of a fixed-dose pen-injector platform device
por: Lange, Jakob, et al.
Publicado: (2018)

Assessing usability, label comprehension, pen robustness and pharmacokinetics of a self-administered prefilled autoinjector pen of methotrexate in patients with rheumatoid arthritis
por: Pachon, Jaime A, et al.
Publicado: (2014)

Growth hormone treatment in non-growth hormone-deficient children
por: Loche, Sandro, et al.
Publicado: (2014)

A questionnaire-based survey to assess patient satisfaction, ease-of-learning, ease-of-use, injection site pain and overall patient satisfaction of the follitropin-alpha (Gonal-f) filled-by-mass (FbM) prefilled pen compared with other systems of gonadotrophin administration
por: Utsunomiya, Takafumi, et al.
Publicado: (2012)

Lower energy expenditures in infants from obese biological mothers
por: Rising, Russell, et al.
Publicado: (2008)

Energy expenditures & physical activity in rats with chronic suboptimal nutrition
por: Rising, Russell, et al.
Publicado: (2006)

Relationship between maternal obesity and infant feeding-interactions
por: Rising, Russell, et al.
Publicado: (2005)

Effect of switching recombinant human growth hormone: Comparative analysis of phase 3 clinical data
por: Romer, Tomasz, et al.
Publicado: (2011)

Results from an international multicenter trial evaluating the ease-of-use of and preference for a newly developed disposable injection pen for the treatment of growth hormone deficiency in treatment-naïve children and adults
por: Pleil, Andreas M, et al.
Publicado: (2014)

Ease of Use of the Insulin Glargine 300 U/mL Pen Injector in Insulin-Naïve People With Type 2 Diabetes
por: Pohlmeier, Harald, et al.
Publicado: (2017)

SUN-255 PATRO Children, a Multi-Center, Non-Interventional Study of the Long-Term Safety and Efficacy of Omnitrope® in Children Requiring Growth Hormone Treatment: Comparing United States (US) and Rest of World (ROW) Data
por: Backeljauw, Philippe, et al.
Publicado: (2019)

Usability of devices for self-injection: results of a formative study on a new disposable pen injector
por: Lange, Jakob, et al.
Publicado: (2014)

Dose Accuracy, Injection Force, and Usability Assessment of a New Half-Unit, Prefilled Insulin Pen
por: Kappes, Christopher M., et al.
Publicado: (2017)

Semaglutide single‐dose pen‐injector: Post hoc analysis of summative usability testing for weight management
por: Klonoff, David C., et al.
Publicado: (2021)

Ease of Use of the iGlarLixi SoloStar Pen from the LixiLan ONE CAN Pen Sub-Study: Questionnaire Findings from People Living with Type 2 Diabetes and Their HealthCare Providers
por: Yale, Jean-François, et al.
Publicado: (2022)

Three years of growth hormone therapy in children born small for gestational age: results from the ANSWER Program
por: Rapaport, Robert, et al.
Publicado: (2018)

Usability and Teachability of Continuous Glucose Monitoring Devices in Older Adults and Diabetes Educators: Task Analysis and Ease-of-Use Survey
por: Psavko, Simon, et al.
Publicado: (2022)

Mini Review/Commentary: Growth Hormone Treatment in Children with Type 1 Diabetes
por: Bonfig, Walter, et al.
Publicado: (2019)

No longer at ease
por: Achebe, Chinua

Easing pain
por: Bernard, Carrie
Publicado: (2023)

The Pen
Publicado: (1949)

The accuracy and precision of insulin administration using human and veterinary pen‐injectors and syringes for administration of insulin
por: Malerba, Eleonora, et al.
Publicado: (2021)

Comparison of Usability, Accuracy, Preference, and Satisfaction Among Three Once-Weekly GLP-1 Receptor Agonist Pen Devices
por: Zhou, Anna Y., et al.
Publicado: (2018)

Patient Acceptance, Ease of Use, and Preference for Norditropin NordiFlex with NordiFlex PenMate: Results from an Open-Label, User Survey of Everyday Use
por: Hokken-Koelega, Anita, et al.
Publicado: (2011)

Ease‐of‐use and acceptability of the novel semaglutide 2.4 mg single‐dose pen‐injector in people with overweight or obesity in the STEP 8 phase III trial
por: Snitker, Søren, et al.
Publicado: (2022)

Usability and ease of use of long-term remote monitoring of physical activity for individuals with acquired brain injury in community: a qualitative analysis
por: Mazzeo, Marie, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_lnf3tfd4mqs0d3vrrofoe52k7c